Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUINAPRIL/HCTZ | 12.5MG 10MG | TABLET | Resolved | 2022-03-25 | 2025-07-11 | 157326 |
| APO-QUININE | 300MG | CAPSULE | Resolved | 2017-09-04 | 2018-04-17 | 20894 |
| APO-QUININE | 200MG | CAPSULE | Resolved | 2017-12-14 | 2018-04-17 | 32809 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Resolved | 2017-03-11 | 2017-05-23 | 466 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Resolved | 2017-04-11 | 2017-05-25 | 6516 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Resolved | 2017-07-11 | 2017-07-27 | 15375 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Resolved | 2018-07-04 | 2018-07-17 | 54309 |
| APO-RALOXIFENE | 60MG | TABLET | Resolved | 2020-06-24 | 2020-11-02 | 118772 |
| APO-RALOXIFENE | 60MG | TABLET | Resolved | 2023-01-13 | 2023-04-21 | 181104 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2017-03-12 | 2017-03-16 | 731 |
| APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2017-03-12 | 2017-03-16 | 734 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2017-04-07 | 2017-06-09 | 6000 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2017-05-02 | 2017-06-09 | 8705 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2017-05-02 | 2017-06-08 | 8707 |
| APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2017-05-24 | 2017-06-21 | 11087 |
| APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2017-06-06 | 2017-08-28 | 12074 |
| APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2017-06-21 | 2017-11-21 | 13475 |
| APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2017-06-28 | 2017-11-20 | 14204 |
| APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2017-06-28 | 2017-11-09 | 14207 |
| APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2017-06-28 | 2018-03-29 | 14210 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
| APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
| APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
| APO-LEVOCARB | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |
| APO-LISINOPRIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60579 |
| APO-LISINOPRIL | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-26 | 60582 |
| APO-LISINOPRIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60585 |
| APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
| APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
| APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
| APO-LITHIUM CARBONATE | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60588 |
| APO-LOPERAMIDE | 2MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4930 |
| APO-LORAZEPAM | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
| APO-LORAZEPAM | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |
| APO-LOSARTAN | 50MG | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 60987 |
| APO-LOSARTAN | 100MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71213 |
| APO-LOSARTAN | 25MG | TABLET | Discontinued | 2019-02-01 | 2019-02-02 | 74376 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60597 |
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60600 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |